We have revealed those lower serum PON-1 levels in obese PCOS patients may be a reliable marker to show metabolic dysfunction. Further studies in larger cohorts with more sensitive tests are needed to prove the specific activity of serum PON-1 in obese PCOS patients. The gene discussed is PON1; the disease is polycystic ovary syndrome.